Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company.

A number of research analysts have weighed in on RHHBY shares. Hsbc Global Res lowered shares of Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. HSBC lowered shares of Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th.

Roche Price Performance

OTCMKTS:RHHBY traded down $0.59 during trading hours on Friday, reaching $39.69. The company's stock had a trading volume of 657,711 shares, compared to its average volume of 2,472,774. Roche has a one year low of $34.10 and a one year high of $44.31. The business's 50-day moving average is $40.10 and its 200-day moving average is $39.80. The company has a current ratio of 1.48, a quick ratio of 1.20 and a debt-to-equity ratio of 0.85.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in RHHBY. Altrius Capital Management Inc increased its stake in Roche by 3.6% in the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock valued at $7,818,000 after acquiring an additional 6,545 shares during the period. Hancock Whitney Corp grew its stake in Roche by 6.8% during the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after buying an additional 1,496 shares during the last quarter. Bard Financial Services Inc. grew its stake in Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after buying an additional 28,050 shares during the last quarter. Rhumbline Advisers grew its stake in Roche by 7.4% during the first quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after buying an additional 7,374 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in Roche by 59.5% during the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock worth $529,000 after buying an additional 4,794 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.